Thermo Fisher Scientific Inc (TMO)
Cash ratio
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 9,852,000 | 4,009,000 | 8,083,000 | 8,524,000 | 4,477,000 |
| Short-term investments | US$ in thousands | 253,000 | 1,561,000 | -1,967,000 | 2,000 | — |
| Total current liabilities | US$ in thousands | 15,189,000 | 13,332,000 | 14,012,000 | 17,010,000 | 13,436,000 |
| Cash ratio | 0.67 | 0.42 | 0.44 | 0.50 | 0.33 |
December 31, 2025 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($9,852,000K
+ $253,000K)
÷ $15,189,000K
= 0.67
Peer comparison
Dec 31, 2025
Company name
Symbol
Cash ratio
Thermo Fisher Scientific Inc
TMO
0.67
Agilent Technologies Inc
A
0.76
Danaher Corporation
DHR
0.68